Abstract
Background Hemodialysis access profoundly impacts the quality of care for chronic kidney disease (CKD) patients worldwide, with arteriovenous fistulas (AVFs) preferred for superior outcomes. Despite global guidelines, Sub-Saharan Africa, including Tanzania, faces challenges, as it relies heavily on nontunneled central venous catheters (CVCs) due to accessibility and financial constraints. We aimed to describe the pattern of vascular access use among CKD patients on maintenance hemodialysis at Muhimbili National Hospital.
Methods A cross-sectional study to describe the pattern of vascular access among patients with CKD on maintenance hemodialysis therapy. Descriptive statistics were used to summarize the baseline characteristics and patterns of vascular access. Our study received ethical clearance from the Muhimbili National Hospital Research Ethics Committee (Ref: MNH/IRB/VOL.1/2024/005). All consent forms were written and provided in English or Swahili.
Results We analysed 200 study participants, with a mean age of 53.3 (14.5) years. Almost all participants initiated hemodialysis with nontunneled central venous catheters (95.5%). A substantial portion continued to use nontunneled CVCs (25.5%), with some transitioning to tunneled CVCs (39.5%) or AVFs (35%). The mean (SD) duration to use nontunneled CVCs before transitioning to tunneled or AVF were 7.1 (2.1) months. Among patients with multiple nontunneled catheters, catheter dislodgement was the main indication for catheter replacement.
Conclusion Our study highlights the prevalent use of nontunneled central venous catheters (CVCs) as the primary vascular access method for CKD patients undergoing hemodialysis at Muhimbili National Hospital, Tanzania. These findings underscore the urgent need for analysis of the cost associated with nontunneled catheter reliance and interventions to improve access to AVFs and enhance vascular access management, ultimately optimizing patient outcomes in resource-limited settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We declare no conflicts of interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from Muhimbili National Hospital, Clinical Research, Training and Consultancy Unit with reference number MNH/IRB/VOL.1/2024/005
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data will be available and accessible upon request to the authors
